The primary limitation of our study is its retrospective nature and
small sample size. In combination with the small sample size, the very
low event rate of major adverse events including death makes statistical
analysis difficult. However, few studies report longitudinal and
complete follow-up of all patients up to 10 years. While we acknowledge
the limitations of this study, we still feel the results indicate that
redo surgery for a failing stentless valve can still be considered a
reasonable option with good long-term outcomes.Acknowledgements/Disclosures:None.Author Contributions:Bindu Bittira: Article concept and design, data analysis and
interpretation, drafting of original article and critical revision,
longitudinal data collection.
Derek MacDonald: Article concept and design, data analysis and
interpretation, drafting of original article and critical revision,
longitudinal data collection.
Mohammed Shurrab: Critical revision of article.
Stacey Santi: Data analysis and interpretation, review of article.
Sarah Grieve: Data collection.References:
Table 1. Population characteristics, preoperative status and
comorbidities of patients who received stentless valve reoperation
(N=24)